ELV vs. CNC, HUM, UNH, SNY, SYK, ISRG, MDT, VRTX, CI, and BSX
Should you be buying Elevance Health stock or one of its competitors? The main competitors of Elevance Health include Centene (CNC), Humana (HUM), UnitedHealth Group (UNH), Sanofi (SNY), Stryker (SYK), Intuitive Surgical (ISRG), Medtronic (MDT), Vertex Pharmaceuticals (VRTX), The Cigna Group (CI), and Boston Scientific (BSX). These companies are all part of the "medical" sector.
Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, community ranking, valuation and profitability.
Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.
In the previous week, Elevance Health had 41 more articles in the media than Centene. MarketBeat recorded 49 mentions for Elevance Health and 8 mentions for Centene. Elevance Health's average media sentiment score of 0.95 beat Centene's score of 0.75 indicating that Centene is being referred to more favorably in the media.
Centene received 180 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 73.24% of users gave Centene an outperform vote while only 66.61% of users gave Elevance Health an outperform vote.
Centene has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500.
Centene currently has a consensus price target of $85.38, suggesting a potential upside of 12.82%. Elevance Health has a consensus price target of $587.42, suggesting a potential upside of 8.85%. Given Elevance Health's higher probable upside, research analysts clearly believe Centene is more favorable than Elevance Health.
93.6% of Centene shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.3% of Centene shares are owned by company insiders. Comparatively, 0.4% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Elevance Health has a net margin of 3.64% compared to Elevance Health's net margin of 1.75%. Centene's return on equity of 20.62% beat Elevance Health's return on equity.
Summary
Elevance Health beats Centene on 13 of the 18 factors compared between the two stocks.
Get Elevance Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ELV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ELV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Elevance Health Competitors List
Related Companies and Tools
